E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Price$100.85
Change (%) Stock is Down 1.06 (1.04%)
Intraday High$102.64
Intraday Low$100.65
Volume992,961
Data as of 02/22/18 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Webcast ImageWebcast - Live
Quest Diagnostics at the Raymond James 39th Annual Institutional Investors Conference
03/06/18 at 1:05 p.m. ET
Quest Diagnostics at the Raymond James 39th Annual Institutional Investors Conference
Tuesday, March 6, 2018 1:05 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
Q4 2017 Quest Diagnostics Earnings Conference Call
02/01/18 at 8:30 a.m. ET
Q4 2017 Quest Diagnostics Earnings Conference Call
Thursday, February 1, 2018 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
Quest Diagnostics at the 36th Annual J.P. Morgan Conference
01/10/18 at 12:00 p.m. ET
Quest Diagnostics at the 36th Annual J.P. Morgan Conference
Wednesday, January 10, 2018 12:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Supporting Materials
Download Event Supporting Material 36th Annual J.P. Morgan Healthcare Conference
Headlines More >
TitleDate
Quest Diagnostics To Speak At The Raymond James 39th Annual Institutional Investors Conference
SECAUCUS, N.J., Feb. 22, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Raymond James 39th Annual Institutional Investors Conference in Orlando. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, March 6, 2018 at ... 
02/22/18
Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter
- Fourth quarter revenues of $1.94 billion, up 4.1% versus 2016 - Fourth quarter diluted EPS of $1.82 on a reported basis, up 67.0% from 2016 primarily due to a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.40 on an adjusted basis excluding amortization, up 6.9% from 2016. Excess tax benefit associated with stock based compensation (ETB) benefited diluted EPS by $0.02 in the quarter and increased $0.01 compared to 2016. - Full year revenues of $7.71 billion, ... 
02/01/18
Quest Diagnostics Completes Acquisition of MedXM
Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilities Secaucus, NJ, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. The acquisition will stren... 
02/01/18
ChartMaxx® from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’
Tenth time ChartMaxx honored with top industry ranking* Secaucus, NJ, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise content management solution ranked number one among Document Management and Imaging (DMI) software products in the 2018 Best in KLAS: Software & Services report, an independent ranking based on customer feedback from healthcare information techno... 
01/30/18
Upcoming EventsMore >
DateTitle
03/06/18 13:05:00 ET
Quest Diagnostics at the Raymond James 39th Annual Institutional Investors Conference
Contact Us:
Shawn Bevec
Executive Director Investor Relations
973-520-2900
Investor@QuestDiagnostics.com

Company Calendar
February 2018?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-4-3-2-1123
45678
02/08/18
SC 13G/A
Formats:  HTML Adobe PDF Word
910
1112
02/12/18
SC 13G/A
Formats:  Excel HTML Adobe PDF Word
13
02/13/18
SC 13G/A
Formats:  Excel HTML Adobe PDF Word
14151617
18192021
02/21/18
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
222324
25262728515253

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.